HOLX — Hologic Inc
NASDAQ · Health Care · Health Care
- Latest Close
- $76.01
- 30-Day Move
- +1.6%
- Market Cap
- $16.9B
- Shares Outstanding
- 223,240,000
- P/E Ratio
- 31.06
- P/B Ratio
- 2.96
Analyst consensus: Hold · 23 analysts
Hologic Inc
A read-only Alphactor snapshot forHologic Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-06
Topline snapshot
Latest Close
$76.01
30-Day Move
+1.6%
Market Cap
$16.9B
Shares Outstanding
223,240,000
P/E Ratio
31.06
P/B Ratio
2.96
$76.01
+1.6%last 90 delayed daily bars
90D High
$76.07
90D Low
$74.19
Avg Volume
4,975,524
Gross margin is running at 56.5%, which gives a quick read on operating quality before you open the full model.
Net margin is 13.2%, useful for comparing HOLX against peers in Health Care.
HOLX is up 1.6% over the last 30 trading days shown on this page.
Latest operating income is $241M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$56.65
Rule of 40
23.8%
Latest Close
$76.01
30-Day Move
+1.6%
Market Cap
$16.9B
Shares Outstanding
223,240,000
P/E Ratio
31.06
P/B Ratio
2.96
ROE
11.2%
ROA
6.3%
Gross Margin
56.5%
Operating Margin
17.6%
Net Margin
13.2%
Debt / Equity
0.5
Current Ratio
3.75
Latest Revenue
$1.0B
Revenue
$1.0B
Gross Profit
$586M
Operating Income
$241M
Net Income
$179M
Gross Margin
5651.0%
Net Margin
1318.0%
Current Ratio
3.75
Debt / Equity
0.50
Fair Value
$56.65
Upside / Downside
-25.5%
Signal
Overvalued
Implied Growth
4.6%
DCF
$43.21
EPV
$37.90
EV/Rev
$88.85
Growth Assumption
-5.5%
Discount Rate
8.4%
Terminal Growth
2.0%
Base FCF
$905M
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Low growth priced in
Altman Z
4.18
Safe
Piotroski
6
Moderate (4-6)
Cash Conversion
1.87x
Rule of 40
23.8%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $4.9B | $1.6B | $1.3B | $2.0B |
| 2023-12-31 | $4.0B | $762M | $456M | $901M |
| 2024-12-31 | $4.0B | $931M | $790M | $1.1B |
| 2025-12-31 | $4.1B | $785M | $566M | $905M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-07 | Liddy Anne M. | D | 3,452 | $0.00 |
| 2026-04-07 | Liddy Anne M. | A | 3,452 | $0.00 |
| 2026-04-07 | Liddy Anne M. | D | 4,683 | $0.00 |
| 2026-04-07 | Liddy Anne M. | D | 7,479 | $0.00 |
| 2026-04-07 | Liddy Anne M. | D | 6,016 | $0.00 |
| 2026-04-07 | Liddy Anne M. | D | 5,121 | $0.00 |
| 2026-04-07 | Liddy Anne M. | D | 5,943 | $0.00 |
| 2026-04-07 | Liddy Anne M. | D | 6,129 | $0.00 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 7,008,595 | 0.03% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 5,612,448 | 0.03% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 5,057,952 | 0.02% | 2025-12-31 |
| Victory Portfolios-Victory Sycamore Established Value Fund | 4,020,000 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 3,261,412 | 0.01% | 2025-12-31 |
| -Price (T.Rowe) U.S. Mid-Cap Growth Equity Trust | 2,950,500 | 0.01% | 2025-09-30 |
| iShares Trust-iShares Core S&P 500 ETF | 2,864,051 | 0.01% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 2,832,457 | 0.01% | 2026-02-28 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
D.E. Shaw
Filed 2026-02-17
--
--
Fisher Investments
Filed 2026-02-09
--
--
Two Sigma Advisers
Filed 2025-11-14
--
--
Vanguard Group
Filed 2026-01-29
$1.9B
-0.5%
BlackRock
Filed 2024-05-10
$1.8B
--
Invesco
Filed 2025-08-13
$543M
+72.5%
Geode Capital Management
Filed 2026-02-09
$439M
+0.4%
2.78
Consensus
Hold—
—
—
23
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.